Autres langues Oriola Oyj

Actions

ORIOLA

FI0009014351

Produits pharmaceutiques

PEA

Temps réel estimé Cboe Europe 16:19:48 18/09/2026			Varia. 5j.	Varia. 1 janv.
0,8850 ^EUR	-0,67 %		-0,79 %	-23,22 %

17/07	Transcript : Oriola Oyj, Q2 2026 Earnings Call, Jul 17, 2026
17/07	Oriola Oyj publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

08:01	Oriola has corrected previously reported financial information
17/09	Publication schedule for Oriola Corporation's financial reporting in 2027
11/09	Oriola Oyj : and Takeda expand Nordic partnership in Finland
10/09	Oriola Oyj : replaces air freight with road transport for vaccine deliveries in northern Sweden
17/07	Tranche Update on Oriola Oyj's Equity Buyback Plan announced on May 8, 2026.
17/07	Oriola Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
17/07	Oriola Corporation's Half-Year Report 1 January-30 June 2026
03/07	Oriola Corporation to publish its Half-Year Report for January-June 2026 on 17 July 2026
17/06	Oriola Oyj : marks start of construction of new distribution centre in Järvenpää
12/06	Nordic Health Group Oriola Wraps Up Share Repurchase Program
12/06	Oriola's share buyback programme has been completed
11/06	Oriola Oyj : selects partner to deliver the automation for Järvenpää distribution centre
10/06	Oriola Oyj: Acquisition of own shares during week 24, 2026
10/06	Composition of Oriola Corporation's Shareholders' Nomination Board
05/06	Oriola Oyj: Acquisition of own shares during week 23, 2026
05/06	Oriola Corporation's Annual Report 2025 published
29/05	Oriola Oyj: Acquisition of own shares during week 22, 2026
22/05	Oriola Oyj: Acquisition of own shares during week 21, 2026
15/05	Oriola Oyj: Acquisition of own shares during week 20, 2026
11/05	Oriola focuses on profitable growth and value creation at Capital Markets Day
08/05	Oriola Oyj: Acquisition of own shares during week 19, 2026
08/05	Oriola Oyj commences an Equity Buyback Plan for 18,500,000 shares, representing 9.98% of its issued share capital, under the authorization approved on March 25, 2026.
08/05	Oriola Oyj : Breakfast event in Helsinki – Nordic insights to accelerate access
30/04	Oriola Corporation - Managers' transactions - Pajamo
30/04	Oriola Corporation - Managers' transactions - Axdorff